Start New EnglishEspañol中文РусскийالعربيةTiếng ViệtFrançaisDeutsch한국어Tagalog Library Performance
BETA v.3.0

2025 CPT code 77750

Infusion or instillation of a radioelement solution to destroy tumor cells, including 3 months of follow-up care.

Follow CPT guidelines for radiology and radiation oncology, paying particular attention to the definitions of simple, intermediate, and complex applications, as well as considerations for high-dose-rate brachytherapy. Note that the use of professional and technical component modifiers (26 and TC) may be dependent on payer policy.

Modifiers 26 (professional component) and TC (technical component) may be appended as appropriate, depending on the provider's role and payer policies.Other modifiers may be necessary in specific circumstances; consult the CPT manual for additional guidance.

Medical necessity is established through the diagnosis and staging of the cancer, the patient's overall health status, and the expected benefits of the procedure relative to risks and alternative treatments.The procedure should be deemed appropriate based on established clinical guidelines and protocols for the specific type of cancer.

The therapeutic radiologist is responsible for the supervision of radioelements and dose interpretation.The procedure may be performed by a physician or other qualified healthcare professional.

IMPORTANT:For administration of radiolabeled monoclonal antibodies, use 79403. For non-antibody radiopharmaceutical therapy by intravenous administration only (excluding 3-month follow-up care), use 79101. For insertion of ovoids and tandems, use 57155. For insertion of Heyman capsules, use 58346. For high dose-rate electronic brachytherapy, see 0394T, 0395T.

In simple words: This procedure uses a radioactive solution to kill cancer cells. The solution is either put directly on the cancer or injected into a vein.The treatment includes a hospital stay and check-ups for three months after.

This CPT code encompasses the infusion or instillation of a radioelement solution for the purpose of destroying cancerous cells.The procedure includes hospital admission and three months of post-procedure follow-up care.The radioelement solution may be instilled directly onto tumor cells (e.g., in pleural or peritoneal cavity tumors) or infused intravenously (e.g., for bone cancers). This method is also known as unsealed internal radiation therapy.

Example 1: A patient with pleural effusion secondary to lung cancer undergoes instillation of a radioelement solution into the pleural space to reduce tumor burden and alleviate symptoms., A patient with metastatic bone cancer receives intravenous infusion of a radioelement solution to target and destroy cancerous cells throughout the skeletal system., A patient with peritoneal carcinomatosis receives intraperitoneal instillation of a radioelement solution to target cancerous cells in the abdominal cavity.

* Complete medical history including diagnosis and staging of cancer.* Detailed description of the procedure performed, including type and amount of radioelement solution used, method of administration, and location of administration.* Documentation of patient's response to treatment, including any adverse events.* Evidence of medical necessity, including clinical indications for using this form of radiation therapy.* Relevant imaging studies (e.g., CT, MRI, PET) before and after the procedure.* Follow-up notes demonstrating the 3-month post-procedure care.

** The cost of the radiopharmaceutical may be billed separately using the appropriate HCPCS code.Pay close attention to payer-specific policies regarding modifier usage and global surgical packages.

** Only Enterprise users with EHR integration can access case-specific answers. Click here to request access.

Discover what matters.

iFrame™ AI's knowledge is aligned with and limited to the materials uploaded by users and should not be interpreted as medical, legal, or any other form of advice by iFrame™.